* Nephros Inc NEPH.OQ reported a quarterly adjusted loss
of 31
cents per share for the quarter ended in September. The mean
expectation of three analysts for the quarter was for a loss
of 11 cents per share.
* Revenue fell 8.6% to $2.41 million from a year ago;
analysts
expected $2.62 million.
* Nephros Inc's reported EPS for the quarter was a loss
of 31
cents.
* The mean earnings estimate of analysts had risen by
about 17.5%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Nephros Inc shares had risen by 15.4% this quarter and
lost 82.2% so far this year.
* The company reported a quarterly loss of $3.23 million.
* Wall Street's median 12-month price target for Nephros Inc
is
$3.63
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
2 at 09:03 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.11 -0.31 Missed
Jun. 30 2022 -0.15 -0.12 Beat
Mar. 31 2022 -0.11 -0.20 Missed
Dec. 31 2021 -0.11 -0.11 Met